Titan Pharmaceuticals

$2.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-4.78%) As of 6:15 PM UTC today

Why Robinhood?

You can buy or sell TTNP and other stocks, options, and ETFs commission-free!

About TTNP

Titan Pharmaceuticals, Inc. engages in development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.

CEO

Sunil Bhonsle, MBA

Employees

Headquarters

South San Francisco, California

Founded

1992

Market Cap

25.10M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

348.79K

High Today

$2.75

Low Today

$2.55

Open Price

$2.74

Volume

414.05K

52 Week High

$14.06

52 Week Low

$2.55

TTNP Earnings

-$0.38

-$0.25

-$0.13

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Available Mar 31, After Hours